• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为从儿科住院医师服务中出院的患者实施便秘行动计划。

Implementation of a Constipation Action Plan for Patients Discharged From a Pediatric Hospitalist Service.

作者信息

Allison Andrew, Sweet Courtney, Knopp Melissa

出版信息

J Pediatr Pharmacol Ther. 2021;26(7):718-722. doi: 10.5863/1551-6776-26.7.718. Epub 2021 Sep 24.

DOI:10.5863/1551-6776-26.7.718
PMID:34588935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8475797/
Abstract

OBJECTIVE

The objective of this study was to determine the effect of a pharmacist-led constipation action plan on the rate of health care utilization.

METHODS

We conducted a prospective research study of patients 2 to 18 years of age admitted to a pediatric hospitalist service for constipation. A study pharmacist developed a patient-specific constipation action plan for each enrolled patient. Data were collected from the electronic medical record, patient/caregiver interview, and follow-up phone calls completed by a pharmacist. The primary outcome was to determine the effect of a pharmacist-led constipation action plan on the rate of health care utilization.

RESULTS

Twenty-seven patients were enrolled in the study. Median (range) age was 9 (2-18) years. Health care utilization of the entire study population decreased from approximately 8.7 encounters per month prior to implementation to approximately 3 encounters per month after implementation. Patients also reported an increase in daily bowel movements from approximately 1 per day prior to implementation to 2 per day post implementation.

CONCLUSIONS

Health care utilization appeared to decrease after implementation of a patient-specific, pharmacist-led constipation action plan.

摘要

目的

本研究的目的是确定由药剂师主导的便秘行动计划对医疗保健利用率的影响。

方法

我们对因便秘入住儿科住院医师服务的2至18岁患者进行了一项前瞻性研究。研究药剂师为每位入组患者制定了针对个体的便秘行动计划。数据从电子病历、患者/护理人员访谈以及药剂师完成的随访电话中收集。主要结果是确定由药剂师主导的便秘行动计划对医疗保健利用率的影响。

结果

27名患者入组本研究。年龄中位数(范围)为9(2 - 18)岁。整个研究人群的医疗保健利用率从实施前每月约8.7次就诊降至实施后每月约3次就诊。患者还报告每日排便次数从实施前的约每天1次增加到实施后的每天2次。

结论

实施针对个体、由药剂师主导的便秘行动计划后,医疗保健利用率似乎有所下降。

相似文献

1
Implementation of a Constipation Action Plan for Patients Discharged From a Pediatric Hospitalist Service.为从儿科住院医师服务中出院的患者实施便秘行动计划。
J Pediatr Pharmacol Ther. 2021;26(7):718-722. doi: 10.5863/1551-6776-26.7.718. Epub 2021 Sep 24.
2
Evaluation of a pharmacist-led antimicrobial stewardship service in a pediatric emergency department.评价药师主导的抗菌药物管理服务在儿科急诊中的应用。
Int J Clin Pharm. 2019 Dec;41(6):1592-1598. doi: 10.1007/s11096-019-00924-1. Epub 2019 Oct 24.
3
Lubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial.鲁比前列酮与番泻叶用于阿片类药物所致便秘的骨科术后患者:一项双盲、活性对照试验
World J Gastroenterol. 2014 Nov 21;20(43):16323-33. doi: 10.3748/wjg.v20.i43.16323.
4
Implementing a Standardized Constipation-Management Pathway to Reduce Resource Utilization.实施标准化便秘管理路径以减少资源利用。
Acad Pediatr. 2018 Nov-Dec;18(8):957-964. doi: 10.1016/j.acap.2018.07.011. Epub 2018 Aug 2.
5
Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).Cochrane系统评价:渗透性和刺激性泻药用于儿童便秘管理(综述)
Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893.
6
Pharmacist-Led Discharge Medication Counseling and its Corresponding Impact on Medication Adherence and Hospital Readmission Rates.由药剂师主导的出院用药咨询及其对用药依从性和再入院率的相应影响。
Innov Pharm. 2020 Jul 31;11(3). doi: 10.24926/iip.v11i3.3352. eCollection 2020.
7
Comparative effectiveness of senna to prevent problematic constipation in pediatric oncology patients receiving opioids: a multicenter study of clinically detailed administrative data.番泻叶预防接受阿片类药物治疗的儿科肿瘤患者便秘问题的比较效果:一项基于临床详细管理数据的多中心研究
J Pain Symptom Manage. 2014 Aug;48(2):272-80. doi: 10.1016/j.jpainsymman.2013.09.009. Epub 2013 Dec 8.
8
Impact of pharmacist-led medication management in care transitions.药师主导的药物管理在护理转接中的影响。
BMC Health Serv Res. 2017 Nov 13;17(1):722. doi: 10.1186/s12913-017-2684-3.
9
Pediatric Gastrojejunostomy Tube Replacement: Effects of Communication on the Need for After-Hours Procedures.小儿胃空肠造口管置换:沟通对非工作时间手术需求的影响。
J Pediatr Gastroenterol Nutr. 2016 Sep;63(3):e27-30. doi: 10.1097/MPG.0000000000001267.
10
Pharmacist-Led Model to Reduce Hospital Readmissions in Medically Complex Children.由药剂师主导的降低患有复杂疾病儿童再次入院率的模式。
J Pediatr Pharmacol Ther. 2016 Jul-Aug;21(4):346-352. doi: 10.5863/1551-6776-21.4.346.

引用本文的文献

1
Evaluation of Patient-Driven Constipation Action Plans for Patients Discharged From a Pediatric Hospitalist Service.针对从儿科住院医师服务中出院的患者的患者驱动便秘行动计划评估。
J Pediatr Pharmacol Ther. 2025 Jun;30(3):384-386. doi: 10.5863/JPPT-24-00115. Epub 2025 Jun 9.

本文引用的文献

1
PEG 3350 Versus Lactulose for Treatment of Functional Constipation in Children: Randomized Study.PEG 3350 与乳果糖治疗儿童功能性便秘的随机研究。
J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):318-324. doi: 10.1097/MPG.0000000000002192.
2
Implementing a Standardized Constipation-Management Pathway to Reduce Resource Utilization.实施标准化便秘管理路径以减少资源利用。
Acad Pediatr. 2018 Nov-Dec;18(8):957-964. doi: 10.1016/j.acap.2018.07.011. Epub 2018 Aug 2.
3
Polyethylene Glycol Maintenance Treatment for Childhood Functional Constipation: A Randomized, Placebo-controlled Trial.聚乙二醇维持治疗儿童功能性便秘:一项随机、安慰剂对照试验。
J Pediatr Gastroenterol Nutr. 2018 Dec;67(6):732-737. doi: 10.1097/MPG.0000000000002070.
4
Follow-up in Childhood Functional Constipation: A Randomized, Controlled Clinical Trial.儿童功能性便秘的随访:一项随机对照临床试验。
J Pediatr Gastroenterol Nutr. 2016 Apr;62(4):594-9. doi: 10.1097/MPG.0000000000000974.
5
Chronic functional constipation in children: adherence and factors associated with drug treatment.儿童慢性功能性便秘:药物治疗的依从性及相关因素。
J Pediatr Gastroenterol Nutr. 2014 May;58(5):598-602. doi: 10.1097/MPG.0000000000000255.
6
Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN.婴幼儿功能性便秘的评估与治疗:欧洲儿科胃肠病、肝病和营养学会(ESPGHAN)及北美儿科胃肠病、肝病和营养学会(NASPGHAN)的循证推荐意见
J Pediatr Gastroenterol Nutr. 2014 Feb;58(2):258-74. doi: 10.1097/MPG.0000000000000266.
7
Health utilization and cost impact of childhood constipation in the United States.美国儿童便秘的医疗利用情况及成本影响
J Pediatr. 2009 Feb;154(2):258-62. doi: 10.1016/j.jpeds.2008.07.060. Epub 2008 Sep 25.
8
A randomized, prospective, comparison study of polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence.一项针对便秘和大便失禁儿童的聚乙二醇3350(无电解质)与氧化镁乳的随机、前瞻性对照研究。
Pediatrics. 2006 Aug;118(2):528-35. doi: 10.1542/peds.2006-0220.
9
Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children.聚乙二醇3350与乳果糖治疗儿童慢性便秘的比较。
Clin Pediatr (Phila). 2002 May;41(4):225-9. doi: 10.1177/000992280204100405.